Cleveland Clinic Florida opened the 107,000-sf Florida Research & Innovation Center in July of 2020 in Port St. Lucie. Accelerating the translation of medical discoveries into innovative therapeutics for clinical treatment, the facility will provide leading-edge laboratories for research programs in immuno-oncology and infectious diseases, such as Zika virus and SARS-CoV-2. The center includes BSL-3 biocontainment suites, administrative offices, meeting rooms, and an area for training programs.
The Florida Research and Innovation Center, which will be closely integrated with Cleveland Clinic’s new Center for Global and Emerging Pathogens Research, will also support collaborative drug development with the Lerner Research Institute’s Center for Therapeutics Discovery.
